Welcome to our dedicated page for Galexxy Holdings news (Ticker: GXXY), a resource for investors and traders seeking the latest updates and insights on Galexxy Holdings stock.
Galexxy Holdings Inc. reports company developments tied to its shift toward health and wellness products, including functional mushroom, adaptogen and nootropic formulations. News about GXXY centers on Adaptin, direct-to-consumer and direct-sales channels, ownership of mushroom-based product intellectual property, marketing partnerships, and customer acquisition efforts in the wellness market.
Company updates also cover governance and management changes, brand and product agreements, sales-technology initiatives, and the historical role of business units such as Wellbeing Farms and VendGenie as Galexxy redirected resources away from CBD and hemp activities.
Adaptin, a new wellness brand, announced its launch on June 25, 2024, aiming to bring functional adaptogens and nootropics to a global audience through innovative marketing strategies. The US adaptogen and functional mushroom supplements market was valued at $40 billion in 2023, part of the $5.7 trillion global wellness market. The brand offers products like natural and organic gummies and elixirs designed to combat anxiety, stress, lack of sleep, and focus issues. Adaptin's proprietary 100-day extraction process ensures high-quality blends. The company plans a preview in Q3 2024 and a full launch in October 2024, with opportunities for early access and profit-sharing.
Galexxy Holdings (OTC PINK:GXXY) has elected Tyler Whitehead to its board of directors. Whitehead is the co-founder and CEO of Adaptin, former CEO of Arbonne, and was President for Nu Skin Enterprises. Over 20 years, he has driven growth in the wellness sector, with experience in global markets, innovation, and legal and risk management. His recent role at Arbonne involved transforming the brand through digital and sustainable business models. Whitehead aims to leverage his expertise to expand Galexxy's reach in the $4.6 trillion global wellness market.
Galexxy Holdings Inc. announces the creation of a new company, Adaptin, , focusing on the functional mushroom and adaptogen market. Adaptin aims to tap into the rapidly growing $32B global market by offering innovative products and business models. Tyler Whitehead is appointed as CEO and Co-Founder, with Galexxy maintaining a 56.5% ownership stake. The partnership aims to drive innovation, expand globally, and enhance customer engagement.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.